Biotech rockstars snag top posts at fast-growing Peninsula company
A fast-growing Peninsula genetic diseases drug developer has signed up a trio of biotech rock stars with r ésumés crisscrossing Genentech Inc., 23andMe Inc., UCSF and high-profile Bay Area startups.
Richard Scheller, Frank McCormick and Charles Homcy have joined BridgeBio Pharma Inc. (NASDAQ: BBIO) over the past six months, as the Palo Alto company moves a series of experimental drugs focused on genet ic diseases through clinical trials.
BridgeBio last month grossed at least $348 million through…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news